Brain Cancer News

Brain Cancer News

Researchers Reveal Racial Disparities in Access to Remdesivir for Patients With Cancer and COVID-19

Publish Date July 24, 2020

Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.

Conflicts of Interest Continue to Plague Oncology Guidelines and Research

Publish Date July 15, 2020

New research presented at ASCO 2020 sheds light on conflicts of interest among NCCN panelists and links industry dollars to measures of academic success among junior faculty.

Why Cancer Centers May Need to Rethink the Hard Sell to Patients

Publish Date July 14, 2020

Two recent papers are encouraging cancer center executives to rethink how they position their services to potential patients.

FDA Grants Orphan Drug Status to Berubicin for Malignant Gliomas

Publish Date June 16, 2020

he designation is supported by data from a phase 1 trial conducted by Reata Pharmaceuticals in 2016. Findings from the study showed 44% of patients treated with berubicin (n=11 out of 25) experienced a statistically significant improvement in progression free survival.

Has the Time for At-Home Cancer Care Finally Come?

Publish Date June 10, 2020

A Penn Medicine team debuts its program focused on cancer care at home — just in time for COVID-19.

CheckMate 143: Nivolumab Produces Disappointing Results in Patients with Recurrent Glioblastoma

Publish Date June 4, 2020

Nivolumab monotherapy fails to improve OS compared to bevacizumab in the treatment of recurrent glioblastoma.

Genomics Industry Tries New Strategies to Engage Community Oncologists

Publish Date May 21, 2020

Streamlined prescribing and reimbursement, patient education tools aim to overcome barriers to adoption of genetic testing.

A New Look at the Dose-Response Relationship in Phase 1 Oncology Trials

Publish Date May 13, 2020

The new generation of cancer drugs behave quite differently than cytotoxic therapies, and that may mean phase 1 trials need to be updated.

Short Treatment Delays May Not Hamper Survival in Glioblastoma

Publish Date May 7, 2020

For patients with glioblastoma, short delays in the initiation of chemoradiotherapy after surgery were not linked to worse survival — yet initiation too soon was.

Researchers Turn to Crowdsourcing to Learn More About COVID-19 and Cancer

Publish Date May 7, 2020

Pooling data from physicians and patients appears to be an efficient way to answer urgent questions.

Fewer Children Enrolling in Pediatric Cancer Trials

Publish Date May 6, 2020

Adolescent and young adult cancer patients underrepresented in clinical trials.

Pediatric Brain Cancer Outcomes Worse for Black, Hispanic Patients

Publish Date April 30, 2020

Disparities for disease severity not seen at diagnosis, meaning postdiagnosis factors may affect outcome.

Pedmark Receives Priority Review for Prevention of Cisplatin-Induced Ototoxicity

Publish Date April 15, 2020

The application is supported by data from 2 pivotal open-label, randomized phase 3 trials (SIOPEL 6 and ACCL0431), which compared the efficacy of sodium thiosulfate plus cisplatin to cisplatin alone for the prevention of cisplatin-induced hearing loss.

Time to Radiotherapy After Glioblastoma Resection Affects Survival Outcomes

Publish Date March 31, 2020

A large retrospective analysis demonstrated that a delay of 4 to 8 weeks for adjuvant radiotherapy following surgical resection of glioblastoma improved survival.

Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation

Publish Date March 24, 2020

The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing.

“Medical Distancing” May Help Protect Cancer Patients From Exposure to COVID-19

Publish Date March 17, 2020

Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection.

Federal Ruling Puts Pressure on Clinical Trial Sponsors to Post Data

Publish Date March 11, 2020

A federal ruling will force trial sponsors to post basic results on ClinicalTrials.gov, but it is unclear whether this is a feasible mandate.

Peptide Derived From Scorpion Venom Helps CAR-T Cells Kill Gliomas in Preclinical Tests

Publish Date March 9, 2020

Researchers have engineered CAR-T cells to express a peptide from scorpion venom to help them home to glioma cells.

First Human Clinical Trial in US to Test the Use of CRISPR-Modified T Cells in Cancer Answers Vital Questions

Publish Date March 5, 2020

CRISPR-modified T cells were used in 3 patients with advanced cancer for the first time, showing modest results on tumor growth.

Improving Cancer Pain Management Amid the Opioid Crisis

Publish Date March 3, 2020

Research into opioid alternatives for cancer-related pain has stalled, however substance use disorders remain problematic.